295 related articles for article (PubMed ID: 37439386)
41. Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway.
Zhang X; Zhu M; Wang H; Song Z; Zhan D; Cao W; Han Y; Jia J
Gene; 2021 Jan; 766():145163. PubMed ID: 32980450
[TBL] [Abstract][Full Text] [Related]
42. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
[TBL] [Abstract][Full Text] [Related]
43. Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt/β-catenin signaling pathway.
Fang D; Wang MR; Guan JL; Han YY; Sheng JQ; Tian DA; Li PY
Exp Cell Res; 2021 Sep; 406(2):112727. PubMed ID: 34370992
[TBL] [Abstract][Full Text] [Related]
44. The significance of EphA2-regulated Wnt/β-catenin signal pathway in promoting the metastasis of HBV-related hepatocellular carcinoma.
Wang Y; Zhang Z; Zhu Z; Wang P; Zhang J; Liu H; Li J
Mol Biol Rep; 2023 Jan; 50(1):565-575. PubMed ID: 36350420
[TBL] [Abstract][Full Text] [Related]
45. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β/catenin and TGF/β-EMT signaling pathways.
Liu Z; Zhang Y; Xu Z
J BUON; 2018; 23(1):188-192. PubMed ID: 29552782
[TBL] [Abstract][Full Text] [Related]
46. CircZFR promotes hepatocellular carcinoma progression through regulating miR-3619-5p/CTNNB1 axis and activating Wnt/β-catenin pathway.
Tan A; Li Q; Chen L
Arch Biochem Biophys; 2019 Jan; 661():196-202. PubMed ID: 30468709
[TBL] [Abstract][Full Text] [Related]
47. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
Jin Y; Wang J; Han J; Luo D; Sun Z
Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
[TBL] [Abstract][Full Text] [Related]
48. DEAH-box polypeptide 32 promotes hepatocellular carcinoma progression via activating the β-catenin pathway.
Hu X; Yuan G; Li Q; Huang J; Cheng X; Chen J
Ann Med; 2021 Dec; 53(1):437-447. PubMed ID: 33729094
[TBL] [Abstract][Full Text] [Related]
49. β-Sitosterol suppresses hepatocellular carcinoma growth and metastasis via FOXM1-regulated Wnt/β-catenin pathway.
Chen Y; Yang Y; Wang N; Liu R; Wu Q; Pei H; Li W
J Cell Mol Med; 2024 Feb; 28(3):e18072. PubMed ID: 38063438
[TBL] [Abstract][Full Text] [Related]
50. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
[TBL] [Abstract][Full Text] [Related]
51. NTS/NTR1 co-expression enhances epithelial-to-mesenchymal transition and promotes tumor metastasis by activating the Wnt/β-catenin signaling pathway in hepatocellular carcinoma.
Ye Y; Long X; Zhang L; Chen J; Liu P; Li H; Wei F; Yu W; Ren X; Yu J
Oncotarget; 2016 Oct; 7(43):70303-70322. PubMed ID: 27611941
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-194 inhibits cell invasion and migration in hepatocellular carcinoma through PRC1-mediated inhibition of Wnt/β-catenin signaling pathway.
Tang H; Zhao H; Yu ZY; Feng X; Fu BS; Qiu CH; Zhang JW
Dig Liver Dis; 2019 Sep; 51(9):1314-1322. PubMed ID: 30948333
[TBL] [Abstract][Full Text] [Related]
53. Metadherin-PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT-β-catenin signaling pathway.
Zhu K; Peng Y; Hu J; Zhan H; Yang L; Gao Q; Jia H; Luo R; Dai Z; Tang Z; Fan J; Zhou J
Carcinogenesis; 2020 Apr; 41(2):130-138. PubMed ID: 31498866
[TBL] [Abstract][Full Text] [Related]
54. A novel O
Xing Y; Hu Y; Zou H; Xie H; Jiang T; Liu L
Toxicol In Vitro; 2022 Oct; 84():105456. PubMed ID: 35985571
[TBL] [Abstract][Full Text] [Related]
55. Salt-inducible kinase 2 functions as a tumor suppressor in hepatocellular carcinoma.
Li Y; Yu J; Jia M; Ma P; Dong C
Environ Toxicol; 2021 Dec; 36(12):2530-2540. PubMed ID: 34491613
[TBL] [Abstract][Full Text] [Related]
56. Long non-coding RNA SUMO1P3 promotes hepatocellular carcinoma progression through activating Wnt/β-catenin signalling pathway by targeting miR-320a.
Wu S; Chen S; Lin N; Yang J
J Cell Mol Med; 2020 Mar; 24(5):3108-3116. PubMed ID: 31970876
[TBL] [Abstract][Full Text] [Related]
57. PNMA1, regulated by miR-33a-5p, promotes proliferation and EMT in hepatocellular carcinoma by activating the Wnt/β-catenin pathway.
Liu P; Chen B; Gu Y; Liu Q
Biomed Pharmacother; 2018 Dec; 108():492-499. PubMed ID: 30243081
[TBL] [Abstract][Full Text] [Related]
58. Compound Kushen Injection intervenes metabolic reprogramming and epithelial-mesenchymal transition of HCC via regulating β-catenin/c-Myc signaling.
Wang KX; Du GH; Qin XM; Gao L
Phytomedicine; 2021 Dec; 93():153781. PubMed ID: 34649212
[TBL] [Abstract][Full Text] [Related]
59. TRIM32 promotes cell proliferation and invasion by activating β-catenin signalling in gastric cancer.
Wang C; Xu J; Fu H; Zhang Y; Zhang X; Yang D; Zhu Z; Wei Z; Hu Z; Yan R; Cai Q
J Cell Mol Med; 2018 Oct; 22(10):5020-5028. PubMed ID: 30079558
[TBL] [Abstract][Full Text] [Related]
60. KIF2C: a novel link between Wnt/β-catenin and mTORC1 signaling in the pathogenesis of hepatocellular carcinoma.
Wei S; Dai M; Zhang C; Teng K; Wang F; Li H; Sun W; Feng Z; Kang T; Guan X; Xu R; Cai M; Xie D
Protein Cell; 2021 Oct; 12(10):788-809. PubMed ID: 32748349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]